BioMarin Pharmaceutical is a biotechnology company based in California that develops and makes medicines for rare genetic disorders. Its treatments address conditions such as phenylketonuria, certain mucopolysaccharidoses and achondroplasia, and it also works on gene therapy for inherited blood and eye conditions. The company serves patients and specialist physicians through hospitals and treatment centres, with its products distributed in markets across North America, Europe and other regions.
On this site BioMarin Pharmaceutical Inc. appears as a stock on the London Stock Exchange (UK), code 0HNC, with prices in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #2356 of 3788 on the London Stock Exchange · confidence Medium
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
48/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-5.1%
From 52-week high-21.5%
MomentumWeak
41/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-8.9%
6-month return3.2%
Stability (higher is calmer)Fair
56/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)36.1%
Worst drawdown, 1 year (smaller is calmer)-23.2%
LiquidityWeak
28/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.08M USD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 49.39 – 70.85Daily closes, split-adjusted
Signals
50-day average61.37
200-day average58.47
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.65
Technical summary
Daily
Strongly bearish
1 bullish · 4 neutral · 10 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 6 bearish
Monthly
Strongly bearish
0 bullish · 0 neutral · 1 bearish
Moving averages (daily)
SMA 10
55.63
Bearish
EMA 10
55.80
Bearish
SMA 20
56.10
Bearish
EMA 20
56.79
Bearish
SMA 50
61.37
Bearish
EMA 50
59.17
Bearish
SMA 100
60.53
Bearish
EMA 100
59.58
Bearish
SMA 200
58.47
Bearish
EMA 200
–
n/a
Oscillators (daily)
RSI (14)
40.25
Neutral
MACD (12, 26)
-1.54
Bearish
Momentum (12)
1.13
Bullish
Stochastic %K (14)
42.39
Neutral
Williams %R (14)
-57.61
Neutral
CCI (20)
-35.26
Neutral
Pivot points (classic, last session)
S3
54.69
S2
55.07
S1
55.27
Pivot
55.65
R1
55.85
R2
56.23
R3
56.43
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.
